Trials / Completed
CompletedNCT06629857
A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
Clinical Correlation of Alpha-Fetoprotein in Hepatocellular Carcinoma: a Cross-Sectional Study from Southeast Asia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 94 (actual)
- Sponsor
- Darul Sehat Hospital · Academic / Other
- Sex
- All
- Age
- 27 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to explore the levels of alpha-fetoprotein (AFP), a protein often elevated in liver cancer, in patients with hepatocellular carcinoma (HCC). The goal is to determine whether AFP levels vary based on the size of the liver tumor or other health conditions like hepatitis B, hepatitis C, and obesity. By analyzing data from 94 patients, the study seeks to identify factors that influence AFP levels, which may help in understanding liver cancer progression and improving diagnosis and treatment approaches.
Conditions
Timeline
- Start date
- 2022-10-30
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2024-10-08
- Last updated
- 2024-10-08
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06629857. Inclusion in this directory is not an endorsement.